u
uMed combines RWE with the power of patient generated data to address the evidence gaps in life science research. By leveraging uMed’s ACCESS Research Platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples.
Investor insights
Funding rounds participated in
$13M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Research Services
Sectors
Research Services
Date founded
2018
Funding rounds raised
Total raised
$13M
from investors over 1 rounds
u
uMed raised $13M on August 4, 2023